| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Wanbury Limited (NSE: WANBURY)
WANBURY Technical Analysis
5
| As on 25th Apr 2024 WANBURY SHARE Price closed @ 158.65 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 28.91 & Strong Buy for SHORT-TERM with Stoploss of 50.26 we also expect STOCK to react on Following IMPORTANT LEVELS. |
WANBURYSHARE Price
| Open | 163.00 | Change | Price | % |
| High | 163.00 | 1 Day | -3.05 | -1.89 |
| Low | 156.45 | 1 Week | 10.40 | 7.02 |
| Close | 158.65 | 1 Month | 133.30 | 525.84 |
| Volume | 53350 | 1 Year | 133.30 | 525.84 |
| 52 Week High 37.50 | 52 Week Low 16.30 | ||||
NSE INDIA Most Active Stocks
| IDEA | 13.90 | 6.11% |
| YESBANK | 25.95 | 1.96% |
| KOTAKBANK | 1642.45 | -10.87% |
| SOUTHBANK | 30.40 | 4.47% |
| SAIL | 164.95 | 0.18% |
| PNB | 135.90 | 2.18% |
| TATASTEEL | 167.70 | 1.30% |
| AXISBANK | 1127.00 | 6.00% |
| IRFC | 150.25 | 0.84% |
| IOB | 66.90 | 5.77% |
NSE INDIA Top Gainers Stocks
| ROML | 75.65 | 19.98% |
| POWERINDIA | 9329.50 | 13.60% |
| GPTINFRA | 211.80 | 12.51% |
| NEOGEN | 1557.75 | 12.25% |
| PNC | 65.00 | 11.02% |
| PNC | 65.00 | 11.02% |
| PNC | 65.00 | 11.02% |
| PNC | 65.00 | 11.02% |
| MOIL | 430.70 | 10.88% |
| GODFRYPHLP | 3449.70 | 10.17% |
NSE INDIA Top Losers Stocks
| WANBURY Daily Charts |
WANBURY Intraday Charts |
Whats New @ Bazaartrend |
WANBURY Free Analysis |
|
|
WANBURY Important Levels Intraday
| RESISTANCE | 171.27 |
| RESISTANCE | 167.22 |
| RESISTANCE | 164.72 |
| RESISTANCE | 162.22 |
| SUPPORT | 155.08 |
| SUPPORT | 152.58 |
| SUPPORT | 150.08 |
| SUPPORT | 146.03 |
WANBURY Target April 2024
| 4th UP Target | 42.89 |
| 3rd UP Target | 37.26 |
| 2nd UP Target | 33.79 |
| 1st UP Target | 30.31 |
| 1st DOWN Target | 20.39 |
| 2nd DOWN Target | 16.91 |
| 3rd DOWN Target | 13.44 |
| 4th DOWN Target | 7.81 |
WANBURY Weekly Target
| 4th UP Target | 194.78 |
| 3rd UP Target | 181.06 |
| 2nd UP Target | 172.58 |
| 1st UP Target | 164.10 |
| 1st DOWN Target | 139.90 |
| 2nd DOWN Target | 131.42 |
| 3rd DOWN Target | 122.94 |
| 4th DOWN Target | 109.22 |
WANBURY Target2024
| 4th UP Target | 42.89 |
| 3rd UP Target | 37.26 |
| 2nd UP Target | 33.79 |
| 1st UP Target | 30.31 |
| 1st DOWN Target | 20.39 |
| 2nd DOWN Target | 16.91 |
| 3rd DOWN Target | 13.44 |
| 4th DOWN Target | 7.81 |
Wanbury Limited ( NSE INDIA Symbol : WANBURY )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
WANBURY Synopsis Technicals View
| 50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
| 100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
| 200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is 36.01 | Sideways | |
| MFI (14) | MFI is Below 20 | Over Sold | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is Below -80 | Over Sold | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Long Buy | 23.95 | |
| 10 Day Avg Volume | Traded -61.85 % Less then 10 Day Average Volume | ||
WANBURY Other Details
| Segment | BE | |
| Market Capital | 2181423104.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-Specialty & Generic | |
| Offical website | > | |
WANBURY Address
 |
||
WANBURY Latest News
WANBURY Business Profile
Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India. The company offers formulations for gynecology, orthopedics, heamatinics, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner purposes approximately under 70 brands. It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive therapeutic areas. Wanbury Limited also exports its products. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. The company was incorporated in 1988 and is headquartered in Navi Mumbai, India. Address: BSEL Tech Park, B-Wing, Navi Mumbai, India, 400703
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service